Evidence mapPaperPMID 41010490Full record

ReviewNutrients2025

Iron: More than Meets the Eye.

Ethan R Naquin, Richa Garg, William J Chen, Eshani Karmakar, Amogh Prasad, Saicharan Mandadi, Kiran Depala, Jyotsna S Gopianand, Jaya P Gnana-Prakasam

Abstract readReview
In one paragraph

Review in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ethan R NaquinDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.ORCID 0000-0002-6788-8927
Richa GargDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.ORCID 0009-0004-0335-4514
William J ChenDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.ORCID 0000-0002-1494-2475
Eshani KarmakarDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.ORCID 0009-0004-2065-5191
Amogh PrasadDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.
Saicharan MandadiDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.
Kiran DepalaDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.
Jyotsna S GopianandDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.
Jaya P Gnana-PrakasamDepartment of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.ORCID 0000-0003-2259-9213

Funding

Iron and Diabetic RetinopathyR01EY031008 · NEI · SAINT LOUIS UNIVERSITY · PI Jaya Pranava Gnana-Prakasam · 2022 to 2024
$1.1M
NEI NIH HHS R01 EY031008NIH HHS 1R01EY031008-05
6 · The paper itself

Abstract

Iron is an essential micronutrient integral to ocular physiology, supporting biochemical processes such as mitochondrial respiration, DNA synthesis and phototransduction. Disruptions in systemic or local iron homeostasis, whether due to overload or deficiency, have been increasingly implicated in the pathogenesis of a broad range of anterior and posterior segment ocular disorders. Iron deficiency may compromise retinal bioenergetics, impair cellular repair, and increase susceptibility to oxidative stress, while iron overload facilitates the generation of reactive oxygen species, contributing to lipid peroxidation, mitochondrial dysfunction, and ferroptosis. Dysregulated iron metabolism has been associated with several ocular pathologies, including age-related macular degeneration, diabetic retinopathy, glaucoma, retinal detachment, cataracts, and anemic retinopathy. The eye possesses specialized iron regulatory mechanisms involving proteins such as transferrin, ferritin, ferroportin, and hepcidin that govern iron transport, storage, and export across ocular barriers. Aberrations in these pathways are now recognized as contributing factors in disease progression. This narrative review explores the complex dual role of iron overload and deficiency in ocular diseases. It highlights the molecular mechanisms underlying iron-mediated pathologies in both the posterior and anterior segments of the eye, along with the clinical manifestations of iron imbalance. Current therapeutic approaches are discussed, including oral and parenteral iron supplementation for deficiency and emerging chelation-based or antioxidant strategies to address iron overload, while highlighting their limitations. Key challenges remain in developing targeted ocular delivery systems that optimize bioavailability and minimize systemic toxicity. Hence, maintaining iron homeostasis is critical for visual function, and further research is needed to refine therapeutic interventions and clarify the mechanistic role of iron in ocular health and disease.

Indexed as

EyeEye DiseasesIronIron OverloadAnimalsDietary SupplementsHomeostasisHumansIron DeficienciesOxidative StressIronagingchelationcorneaeyeironiron deficiencyiron overloadlensretina

Identifiers

PMID41010490
PMCPMC12472898

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.